Related by context. Frequent words. (Click for all words.) 64 Renal Cell Carcinoma 64 Completes Enrollment 63 Metastatic Melanoma 63 Pivotal Phase 63 II Clinical Trial 63 Patient Enrollment 62 Improves Survival 62 refractory chronic lymphocytic 62 Idiopathic Pulmonary Fibrosis 62 Initiates Phase II 62 Clinical Trial Results 61 Heart Failure Patients 61 Phase III Clinical Trial 61 Chronic Lymphocytic Leukemia 61 Myelofibrosis 61 J Am Acad 61 Commences Phase 61 Initiate Phase 61 Epratuzumab 61 Microplasmin 60 Presents Positive 60 Acute Myocardial Infarction 60 Single Dose 60 Pulmonary Arterial Hypertension 60 Preclinical Data 60 Embolization 60 Relapsed 60 Phase III Trial 60 Carcinoma 60 Pivotal Phase III 60 relapsed refractory multiple myeloma 60 Tesetaxel 60 Chronic Heart Failure 59 ThermoDox R 59 Voreloxin 59 Pivotal Study 59 Initiates Phase 59 Receives Orphan Drug Designation 59 Patients Undergoing 59 Metastatic Colorectal Cancer 59 Drug Candidate 59 Elderly Patients 59 FDA Accepts 59 Phase IIIb 59 HALTS 59 Pivotal Trial 59 KRN# 59 post herpetic neuralgia PHN 59 MKC# 59 phase IIb clinical 58 Chronic Hepatitis C 58 metastatic castration resistant 58 Inhibits 58 ongoing Phase 1b 58 Postmenopausal Women 58 R sorafenib tablets 58 Aliskiren 58 ADAGIO 58 Monotherapy 58 Daclizumab 58 metastatic castrate resistant 57 Ischemic 57 Newly Diagnosed 57 Diabetic Macular Edema 57 Venous Thromboembolism 57 gastrointestinal stromal tumors GIST 57 Well Tolerated 57 Bortezomib 57 Dapagliflozin 57 PREVAIL 57 multi kinase inhibitor 57 Genasense ® 57 Randomized Controlled Trial 57 Meta Analysis 57 plus gemcitabine 57 registrational trial 57 Cell Lung Cancer 56 relapsing multiple sclerosis 56 Hypoactive Sexual Desire Disorder 56 resistant ovarian cancer 56 Drug Resistant 56 liposomal formulation 56 lymphoma CTCL 56 Amrubicin 56 Antihypertensive 56 Phase Ib clinical 56 castrate resistant prostate cancer 56 Phase 2a clinical 56 Patients Treated 56 EDEMA4 56 pseudobulbar affect PBA 56 platinum refractory 56 Alemtuzumab 56 HER2 positive metastatic breast 56 refractory multiple myeloma 56 multicenter prospective 56 Lung Cancer Patients 56 Solid Tumors 56 Targeted Therapy 56 HGS ETR2 56 Tumor Growth